Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Oppenheimer Analyst Maintains Positive Outlook on Clarivate with Revised Price Target

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
SO stock news
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Oppenheimer analyst Owen Lau reaffirms his positive outlook on Clarivate (NYSE:CLVT) with an “Outperform” rating, but has revised the price target down to $10 from $11. This adjustment follows a previous update where the price target was increased from $10 to $11. Analysts have consistently rated Clarivate as “Outperform,” with price targets ranging from $10 to $15. Oppenheimer’s stock recommendations and price targets are highly regarded in the market, offering valuable guidance for investors.

CLVT Stock Plummets 17.45% in One Day: Investors Keep a Close Eye

On February 28, 2024, CLVT stock experienced a significant drop in its price performance. According to CNN Money, the stock closed at $7.38, which marked a decrease of $1.56 or 17.45% since the previous market close. Despite the negative performance during regular trading hours, there was a slight uptick in after-hours trading, with the stock rising $0.06. Investors and analysts will likely be monitoring the stock closely in the coming days to see if this drop in price is indicative of a larger trend or if it was a temporary fluctuation. It will be important to consider any relevant news or developments that may have contributed to the stock’s performance on this particular day.

CLVT Stock Performance Analysis: Mixed Results on February 28, 2024

On February 28, 2024, CLVT stock had mixed performances based on the financial data provided by CNN Money. The total revenue for the company stood at $2.63 billion for the past year, which remained flat compared to the previous year. Similarly, the total revenue for the fourth quarter was $683.70 million, also holding flat compared to the previous quarter.

The net income for CLVT showed contrasting trends. The net income for the past year was reported at -$911.20 million, which represented a 76.99% increase compared to the previous year. On the other hand, the net income for the fourth quarter was reported at -$843.90 million, indicating a significant decrease of 6960.98% compared to the previous quarter.

Earnings per share (EPS) for CLVT also displayed divergent trends. The EPS for the past year was reported at -$1.47, showing a 76.45% increase compared to the previous year. However, the EPS for the fourth quarter was reported at -$1.30, indicating a substantial decrease of 13141.84% compared to the previous quarter.

Overall, the financial performance of CLVT on February 28, 2024, showcased a mix of positive and negative indicators. Investors and analysts would need to closely monitor these financial metrics to assess the future prospects of CLVT stock.

Tags: CLVT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Investings on laptop and finances

Title Payoneer Global Remains Optimistic Despite Revenue Projection Dip

Empowering Beauty The Mission of Purple Boudoir

Pharmaceutical Markets and money

Mixed Results from PL9643 MELODY1 Phase 3 Clinical Trial for Dry Eye Disease

Recommended

Analyst Ratings Show Bullish Sentiments for Boston Scientific

2 years ago
D-Wave Quantum Stock

D-Wave Quantum Shares Surge Ahead of Earnings Report

6 days ago
Finance_Fiscal (2)

Taboolas Strong Financial Performance and Growth Outlook for 2024

2 years ago
Healthcare-and-IT

Analyst Ratings and Price Targets for Evolent Health Recent Updates and Insights

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Ethereum’s Institutional Bet: Whales Accumulate Amid Market Turbulence

Hedge Funds Target Xiaomi as Short Positions Surge Ahead of Earnings

Diginex Expands RegTech Capabilities with Strategic Edge AI Acquisition

Can Strategic Shifts Reverse JetBlue’s Fortunes?

Fannie Mae Shares Face Intensifying Pressure Amid Leadership Overhaul

Technology Sector at a Crossroads: Can AI Momentum Sustain ETF Valuations?

Trending

Block Stock
Analysis

Block Investors Brace for Pivotal Earnings Report

by Dieter Jaworski
November 6, 2025
0

Today marks a critical juncture for Block shareholders as the financial technology firm prepares to release quarterly...

Nestle Stock

Nestlé Faces Dual Setbacks as Patent Denial Meets Analyst Downgrade

November 6, 2025
Redcare Pharmacy Stock

Redcare Pharmacy Shares Defy Strong Performance with Steep Decline

November 6, 2025
Ethereum Stock

Ethereum’s Institutional Bet: Whales Accumulate Amid Market Turbulence

November 6, 2025
Xiaomi Stock

Hedge Funds Target Xiaomi as Short Positions Surge Ahead of Earnings

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Block Investors Brace for Pivotal Earnings Report
  • Nestlé Faces Dual Setbacks as Patent Denial Meets Analyst Downgrade
  • Redcare Pharmacy Shares Defy Strong Performance with Steep Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com